FactSet’s AI Momentum Is Real; Its Guidance Still Does Not Clear 10/5 2026-10 / week-1 Cal-Maine’s Q1 Confirms a Shell-Egg Loss; the Post-Print Short Still Fails 10/5 2026-10 / week-1 Cal-Maine’s Egg Supply Is Growing; the Short Still Fails 10/5 2026-09 / week-5 KMX’s Q2 Volume Rebound Has Not Yet Repaired Unit Economics 2026-09 / week-5 SSTI’s $8 Cash Bid Does Not Clear 10/5 on CVR Optionality 2026-09 / week-5 CNXC’s Q3 EPS Beat Does Not Reverse the Revenue Slope 2026-09 / week-5 QURE Reprices AMT-130’s Four-Year Miss, but the Long Still Fails 10/5 2026-09 / week-5 Conagra’s FY27 Guide Is Weak; the Pre-Report Short Still Fails 10/5 2026-09 / week-5 SMMT’s $18.36 AstraZeneca Price Is Not a Common-Share Floor 2026-09 / week-5 ZYME Adds YUPELRI Cash Flow, but the New Cash Is Pledged First 2026-09 / week-5 FICO Prices Mortgage-Score Competition Before the Grid’s Terms 2026-09 / week-5 AIR’s MRO Deal Adds Scale; the Equity Bridge Still Needs Deleveraging 2026-09 / week-5 ACET’s Lupus Remission Signal Is Promising; Cash Is Not a Floor 2026-09 / week-5 KOD’s DAYBREAK Win Is Real; the $5.5B Equity Case Still Lacks a Long Edge 2026-09 / week-5 KNDI’s H1 Profit Breaks the Pre-Result Short Thesis, but the Gap Still Fails 10/5 2026-09 / week-5 Addex Trades Below Its ATM Price, but Returned Rights Are Not Cash 2026-09 / week-4 Kandi’s Rawrr Deal Adds Revenue, Not Yet Operating Profit 2026-09 / week-4 BARK’s $11 Poll Is Half Its Old Split-Adjusted Bid 2026-09 / week-4 DBRG Series J’s $25 conversion right is not cash yet 2026-09 / week-4 Micron’s $50B Q4 Guide Is a Cycle Test, Not Yet a Short Edge 2026-09 / week-4 Calidi’s Equity Notice Opens a Remedy Window, Not an Immediate Short Catalyst 2026-09 / week-4 GIPR Cleared Loci, but the Reload Warrants Do Not Clear 10/5 2026-09 / week-4 LEGN’s five-year remission data still needs a cash bridge 2026-09 / week-4 Sabre’s tender clears a maturity; it does not clear the leverage 2026-09 / week-4 MIRM’s FOP approval is real; the first-year revenue bridge is not 2026-09 / week-4 WTTR’s Pilot purchase looks cheap on EBITDA, not yet on equity downside 2026-09 / week-4 EquipmentShare’s OWN Program: The Market Prices the Dispute, Not a Verified Loss 2026-09 / week-4 Knife River’s activist margin target is not yet a cash bridge 2026-09 / week-4 BlackBerry’s record QNX win is backlog, not yet a 40x earnings bridge 2026-09 / week-4 Deep Fission’s funding risk is real; a FISN short still fails 10/5 2026-09 / week-4 Host Digital’s contracted rent is not cash flow, but the short still fails 10/5 2026-09 / week-4 Kodiak’s 76 MW award advances the power plan, but not its cash bridge 2026-09 / week-4 Prime Medicine’s IND clearance opens trials, not a 10/5 long 2026-09 / week-4 KITT’s third reverse split lifts the quote, not the cash runway 2026-09 / week-4 Akamai’s $11.6B Anthropic contract is real; its cash return is still a forecast 2026-09 / week-4 MGM’s buyout premium is gone; standalone cash flow still needs to earn its multiple 2026-09 / week-4 Costco’s strong quarter does not make its premium a short catalyst 2026-09 / week-4 Iridium’s vote clears one gate; the merger spread still fails 10/5 2026-09 / week-4 Scholastic’s comparable Q1 nearly held; the cash guide is the test 2026-09 / week-4 SFIX’s 22% regular-session gap leaves little short downside 2026-09 / week-4 